The Latest Breaking News from HIV

A new series of events and exhibitions aim to remember the art made during a devastating time, centered on the powerful Aids quilt

Is shutting down the CDC's HIV prevention division a good idea?

For the past two months, Elsie has been receiving daily calls from desperate children surviving on HIV treatment whom she is not allowed to help.

LGBT+ groups and public health advocates warn against potential threats that could jeopardize progress and ‘set us back decades’

Trump's second term has included pauses to HIV public awareness campaigns and the cancellation of at least 20 grants funding HIV research.

Cuts to foreign aid have resulted in disruptions to life-saving health care in multiple countries

The abrupt halt to US funding threatens to undo decades of advances, dramatically increasing infections and deaths, but some see an opportunity for Africa to lead the response

Christian organizations helped create Pepfar, credited with preventing 25m early deaths, particularly in Africa

Summary Gilead Sciences (GILD) shows strong technical buy signals, with a 19.60% gain since Trend Seeker's buy signal on 1/27 and a 50.31% gain in the last year. The company offers a diverse portfolio of medicines for HIV, COVID-19, liver diseases, oncology, and more, with significant collaborations enhancing its pipeline....

HIV prevention has leaped forward with the development of a yearly injection that may offer long-term protection against the virus. A recent clinical trial has demonstrated promising results, suggesting that this long-acting injectable medication could serve as an effective alternative to daily oral PrEP (Pre-Exposure Prophylaxis). Scientists and medical experts…

Yearly doses could reduce barriers people face to taking preventative HIV medication, researchers said.